Proper psychosocial rehabilitation for stabilised patients with schizophrenia: the role of new therapies
- 31 December 1996
- journal article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 6, 7-12
- https://doi.org/10.1016/0924-977x(96)00011-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Risperidone in the treatment of negative symptoms of schizophreniaInternational Clinical Psychopharmacology, 1995
- S-15-2 Cognitive dysfunction in schizophrenia: Comparison of treatment with a novel atypical antipsychotic agent versus conventional neuroleptic drugsEuropean Neuropsychopharmacology, 1995
- Cognitive therapy with schizophrenic patients: conceptual basis, present state, future directionsActa Psychiatrica Scandinavica, 1994
- Compliance, quality assurance and standards for relapse prevention in schizophreniaActa Psychiatrica Scandinavica, 1994
- Neuroleptics and the Natural Course of SchizophreniaSchizophrenia Bulletin, 1991
- Maintenance Medication for Schizophrenia: Strategies for Dose ReductionSchizophrenia Bulletin, 1991
- II. A Randomised Controlled Trial of Prophylactic Neuroleptic TreatmentThe British Journal of Psychiatry, 1986
- A Heuristic Vulnerability/Stress Model of Schizophrenic EpisodesSchizophrenia Bulletin, 1984
- The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequencesActa Psychiatrica Scandinavica, 1983
- Role of fluphenazine decanoate in lessening the burden of chronic schizophrenics on the communityPsychological Medicine, 1973